CORE
CO
nnecting
RE
positories
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Research partnership
About
About
About us
Our mission
Team
Blog
FAQs
Contact us
Community governance
Governance
Advisory Board
Board of supporters
Research network
Innovations
Our research
Labs
Author response for "A Safety and Pharmacodynamics Study of Temelimab, an anti‐HERV‐W‐Env Monoclonal Antibody, in Type 1 Diabetes Patients"
Authors
null Adam Roberts
null Bernard Champion
+20 more
null Bronwyn Stuckey
null Bénédicte Buffet
null Chris Gilfillan
null Claire Morbey
null Corinne Bernard
null David Lloyd
null David O'Neal
null Elif I Ekinci
null Francois Curtin
null Gabrielle Kornmann
null Hervé Porchet
null Nicole Maëstracci‐Beard
null Parind Vora
null Peter Davoren
null Richard Simpson
null Sally Duke
null Sam Malpass
null Stephen Stranks
null Thomas Nathow
null Trisha O'Moore‐Sullivan
Publication date
14 February 2020
Publisher
Wiley
Doi
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
info:doi/10.1111%2Fdom.14010%2...
Last time updated on 09/03/2025
